{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:23:47Z","timestamp":1777004627051,"version":"3.51.4"},"reference-count":39,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2018,10,3]]},"DOI":"10.1080\/17425247.2018.1518425","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T15:49:27Z","timestamp":1535989767000},"page":"983-989","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders"],"prefix":"10.1080","volume":"15","author":[{"given":"Marc","family":"Brown","sequence":"first","affiliation":[{"name":"MedPharm Ltd, Guildford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Turner","sequence":"additional","affiliation":[{"name":"MedPharm Ltd, Guildford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean Robert","family":"Wevrett","sequence":"additional","affiliation":[{"name":"MedPharm Ltd, Guildford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"CIT0001","unstructured":"U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Patient information for Jublia: FDA drug labels database, 2014. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/203567s000lbl.pdf [last accessed 2018 Jan 11"},{"key":"CIT0002","unstructured":"U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Patient information for penlac\u00ae. FDA drug labels database, 2004. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/21022s004lbl.pdf [last accessed 2018 Jan 11"},{"key":"CIT0003","unstructured":"U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Patient information for kerydin\u00ae. FDA drug labels database, 2014. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/204427s000lbl.pdf [last accessed 2018 Jan 25"},{"key":"CIT0004","unstructured":"Draft Guidance on Ciclopirox. FDA guidance information, 2011. Available at: https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm199631.pdf [last accessed 2018 Jan 25"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1211\/0022357991772448"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1983.tb04258.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9368-3"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb15511.x"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1985.tb04966.x"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1997.tb06127.x"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2003.11.008"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1017\/S0953756201004725"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.3732\/ajb.1000298"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03510.x"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02741.x"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00005.x"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb00722.x"},{"issue":"11","key":"CIT0018","first-page":"762","volume":"88","author":"Westerberg DP","year":"2013","journal-title":"Am Fam Physician"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2014.929138"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1959.01560150001001"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00008.x"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2013.12088"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.3390\/jof1010030"},{"key":"CIT0024","unstructured":"British Journal of Dermatology. British Association of Dermatologists\u2019 guidelines for the management of onychomycosis 2014. Available at: https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.13358 [last accessed 2018 May 15"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.49088"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200305000-00008"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200109000-00021"},{"issue":"6","key":"CIT0028","first-page":"24","volume":"8","author":"Rodriguez DA.Efinaconazole Topical Solution","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3390\/jof1020173"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20773"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1080\/10717540500455975"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-210-6_5"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00731-1"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.62.06.0009"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2016.1201098"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00779-17"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02554-16"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1422078"},{"issue":"1","key":"CIT0039","first-page":"71","volume":"20","author":"Turner R","year":"2016","journal-title":"Int J Pharm Compd"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2018.1518425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:49:30Z","timestamp":1598748570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2018.1518425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,3]]}},"alternative-id":["10.1080\/17425247.2018.1518425"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2018.1518425","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}